Home/ Supplements/ Electrolytes/ Move Free Ultra Mineral Complex

Move Free Ultra Mineral Complex

product on market Tablet or Pill Schiff Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 50% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Calcium is well-supported by strong evidence for maintaining bone density and structural integrity. Calcium fructoborate is included for joint health, though research evidence for this specific compound is limited. The ingredient profile maintains a high safety score with no significant concerns noted.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Move Free Ultra Mineral Complex
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Tablet(s)
Serving Size
Other Combinations
Product Type
50%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calcium
35 mg (3% DV)
Market median: 4002.0mg (1 products) 21 studies (A:0, B:2)

Other Ingredients

Dicalcium Phosphate Microcrystalline Cellulose Hydroxypropyl Cellulose Croscarmellose Sodium Crospovidone Magnesium Silicate Coating Magnesium Stearate Silicon Dioxide
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Tiny & easy-to-take pill: Taking big pills every day can be a challenge. With Move Free Ultra Faster Comfort, you just need to take 1 tiny pill a day instead of 2 large Glucosamine + Chondroitin tablets.

1 tiny pill a day

Directions: Adults (>18 years of age) take one (1) tablet daily.

Warnings & Precautions

Keep out of reach of children.

Not for use by pregnant or breastfeeding women. If on prescribed medication, consult your physician before use.

Not suitable for use by anyone under the age of 18 years old.

Protected with a tamper evident seal. Do not use if seal under cap is broken or missing.

Formulation Notes

Joint health Mineral complex inspired by nature Clinically proven joint comfort Starts working in 7 days plus long term support

Move Free Ultra Faster Comfort uses a mineral complex inspired by nature.

Clinically proven to deliver better joint comfort in as little as 7 days. Provides long term joint comfort that improves over time.

About our ingredients: What is Calcium Fructoborate? Calcium Fructoborate is a unique, clinically proven mineral complex originally discovered in plants that supports cartilage health. Calcium Fructoborate is also thought to help support healthy Vitamin D levels, which are needed to help the body absorb calcium. What is Calcium? Calcium is a mineral essential to bone and muscle health. If our bodies use more calcium than is being replaced, bones will weaken over time.

Additional Information

All tablets shown actual size Move Free Ultra Faster Comfort vs. Glucosamine + Chondroitin Proud partner of the Arthritis Foundation Move Free is proud to support the Arthritis Foundation's efforts to conquer arthritis. For information, call 800-283-7800 or visit arthritis.org Join, earn points & get rewards Move Free Rewards www.movefreerewards.com See cap sticker for detai;s Valid for US residents only. Schiff since 1936

Store in a cool, dry place with lid tightly closed.

Move Free. For what moves you. We believe in delivering clinically proven benefits to keep people connected to what they love most.

Learn more at MoveFree.com

Calcium Fructoborate is clinically proven to deliver comfort than Glucosamine & Chondroitin. Based on data from two 14-day clinical research publications comparing Calcium Fructoborate to placebo with continued use (Pietrzkowski, Z., et. al., Clin Interv Aging, 2014); and Glucosamine & Chondroitin to placebo (Reyes-Izquierdo, T., et al., J Aging Res Clin Pract, 2014). Based on a 90-day randomized placebo controlled clinical study measuring the effect of 216 mg of Calcium Fructoborate (Pietrzkowski, Z., et. at., J Aging Res Clin Pract, 2018).

Metadata

Product Details

UPC / SKU0 20525 98912 3
DSLD Entry Date2020-12-26
Product TypeOther Combinations
FormTablet or Pill
BrandSchiff
DSLD ID241038
Data Updated2026-04-11
Research

Research Evidence

849
Research Sources
56
Avg Quality
450
Meta Analysis
152
Rct
137
Systematic Review
73
Clinical Trial
11
Regulatory Source
7
Other
7
Guideline
3
Openfda Safety
2
Cochrane Review
2
Observational
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008 PubMed DOI
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023 PubMed DOI
A Dietary sodium, sodium-to-potassium ratio, and risk of stroke: A systematic review and nonlinear dose-response meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2019 PubMed DOI
A The association between circulating magnesium and clinically relevant outcomes in patients with chronic kidney disease: A systematic review and meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2021 PubMed DOI
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
View all evidence for Electrolytes →
Compare

Similar Products

View all Electrolytes products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.